ESH Video

John Goldman Award

Submitted projects must:

– aim to develop a method, algorithm or test to reliably identify patients able to benefit from treatment discontinuation, thereby significantly improving the probability of TFR success,

– demonstrate potential to improve healthcare standards for Chronic Myeloid Leukaemia (CML) patients or for patients suffering from other haematological malignancies.

– The recipient of this annual award will receive a total of 80 000€ to finance or co-finance a research project on Treatment Free Remission (TFR).

 

For further information: Didi.jasmin@univ-paris-diderot.fr

European School of Haematology (ESH)

Saint-Louis Research Institute,

Saint-Louis Hospital,

Paris 75010, France

 

 

 

 
5 th International Conference - New Concepts in Lymphoid Malignancies 5th International Conference On Acute Myeloid Leukemia 5th International Conference New Concepts in Lymphoid Malignancies